Based on 1 analyst offering 12 month price targets for Nervgen Pharma Corp
Min Forecast
$18.00+405.62%
Avg Forecast
$18.00+405.62%
Max Forecast
$18.00+405.62%
Should I buy or sell NGEN stock?
Based on 1 analyst offering ratings for Nervgen Pharma Corp.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although NGEN's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates NGEN as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More
Be the first to know when Wall Street analysts revise their NGEN stock forecasts and price targets.
Is Nervgen Pharma Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: NGEN) stock is to Buy NGEN stock.
Out of 1 analyst, 0 (0%) are recommending NGEN as a Strong Buy, 1 (100%) are recommending NGEN as a Buy, 0 (0%) are recommending NGEN as a Hold, 0 (0%) are recommending NGEN as a Sell, and 0 (0%) are recommending NGEN as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year NGEN price target, the average NGEN price target is $18.00, with the highest NGEN stock price forecast at $18.00 and the lowest NGEN stock price forecast at $18.00.
The Wall Street analyst predicted that Nervgen Pharma's share price could reach $18.00 by Apr 27, 2027. The average Nervgen Pharma stock price prediction forecasts a potential upside of 405.62% from the current NGEN share price of $3.56.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.